CXCL8 and cystic fibrosis: Interestingly, pretreatment of CFTRΔF508 cells with IL-17 resulted in a 10-fold increase in IL-8 synthesis following treatment with a NOD1 agonist, highlighting the importance of NOD1 as contributor to aberrant inflammatory responses in the CF lung [95].